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a 65-year-old male presented with hemorrhagic bullous skin lesions with purpura and ecchymoses. there 
was increased skin fragility with a strongly positive nikolsky sign. histopathology of the skin revealed 
large amounts of amyloid deposits in the dermis with a positive congo red staining around the dermal 
vessels. examination and tests in this patient also revealed anemia, hepatomegaly, infiltrative cardiomy-
opathy, polyneuropathy and immunoglobulin l deposition, favoring a diagnosis of primary amyloidosis 
(al type). the present case is reported in view of the rarity of the bullous variant of primary systemic 
amyloidosis as well as presence of mucosal lesions and a positive nikolsky sign.
The amyloidoses are a heterogenous group of disorders characterized by deposition of varitous types of extracellular fibrillar proteins, 
which have in common a typical green birefringence in 
polarized light after Congo red staining of the involved 
tissue specimen.1 Amyloidoses may be divided into 
the systemic, localized and the heredofamilial types. 
Immunohistology allows the identification of the types 
of amyloid based on the composition of the fibrillar 
protein.2 We describe a case of primary systemic amyt
loidosis with multiorgan involvement who presented 
with extensive mucocutaneous bullous lesions with a 
strongly positive Nikolsky sign.
CASE
A 65tyeartold nontdiabetic, normotensive farmer 
presented with a 6tmonth history of a progressively 
worsening bullous skin eruption. Clinical evaluation 
of the patient revealed a history of dysphagia, anorext
ia, hoarseness of voice, paresthesias in the hands and 
feet, and dyspnea and postural hypotension of nearly 
the same duration. There was no history of a similar 
eruption in the past. There was no history of intake 
of any drug and family history was nontcontributory. 
On general physical examination, the patient had palt
lor. Auscultation of the chest revealed decreased breath 
sounds in the right lower chest. The patient also had 
hepatomegaly and hypothenar and thenar muscle 
wasting of both hands.
Cutaneous examination revealed multiple large 
hemorrhagic bullae intermingled with nontpalpable 
purpura, ecchymoses, erosions and waxy plaques pret
dominantly involving the neck, trunk, axillae, lower 
limbs and hands (Figure 1, 2). Hemorrhagic bullae and 
ecchymotic plaques were present on both upper eyelids 
(Figure 3). Yellowishtwhite miliumtlike papules were 
observed on the back. The skin was tender to the touch 
and substantially fragile as revealed by strongly positive 
Nikolsky sign. Purpuric and ecchymotic lesions were 
present on the tongue and hard palate. The patient’s 
tongue was firm on palpation. Longitudinal ridging 
was present in all the fingernails.
 The complete blood count revealed a hemoglobin of 
9.1 g/dL and an erythrocyte sedimentation rate of 60 
mm (first hour reading by Westergen method). Platelet 
count, clotting time, bleeding time, prothrombin and 
activated partial thromboplastin times were within nort
mal limits. Liver function tests and kidney function tests 
were also within normal limits. Twentytfour hour urit
nary protein was 0.54 g/L (total volume 1.3 L), while 
urine for BencetJones proteins was negative. Serum and 
urine protein electrophoresis was negative. Bone mart
row examination was normal. A collagen vascular profile 
of the patient did not reveal any abnormality.
An electrocardiogram showed decreased voltages 
in all standard leads. A chest xtray showed righttsided 
pleural effusion while radiographic examination of 
the skull and pelvis did not reveal any lytic bone lesion. 
Ultrasonographic examination of the abdomen and pelt
vis revealed hepatomegaly (17.7 cm). On echocardiogt
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raphy, infiltrative cardiomyopathy with grade I diastolic 
dysfunction with normal left ventricular systolic funct
tion was seen. Nerve conduction studies showed polyt
neuropathy (axonal more than demyelinating type). 
Fiber optic laryngoscopy revealed bullous lesions on 
the vocal cords while upper gastrointestinal endoscopy 
revealed several erosions in the uppertthird of esophat
gus. 
Histopathological examination of a skin biopsy spect
imen showed an atrophic epidermis with large amounts 
of an amorphous eosinophilic material deposited in the 
dermis and subcutis. The blisters were paucitinflamt
matory and subepidermal (Figure 4). The amorphous 
deposits were positive for Congotred staining with apt
pletgreen birefringence under polarized light and surt
rounded the dermal vessels in a cufftlike manner (Figure 
5). Direct immunofluorescence examination of the skin 
Figure 5. Positive Congo red staining of cutaneous amyloid 
deposits.
Figure 1. Hemorrhagic blister with ecchymoses and erosions on 
the trunk.
Figure 2. ecchymoses and erosions on abdomen.
Figure 3. ecchymotic patches on upper eyelids.
Figure 4. Subepidermal blister on hematoxylin and eosin stain 
(×100).
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biopsy specimen performed to rule out an immunobult
lous disorder, was negative. Abdominal fat pad and rectal 
biopsies were also done and were positive for Congotred 
staining. Immunohistochemical staining showed posit
tive staining for immunoglobulin l light chain. 
Keeping the abovetmentioned constellation of 
clinical and laboratory parameters in mind, a diagnot
sis of primary systemic amyloidosis (AL amyloidosis) 
was entertained. The patient was put on intravenous 
dexamethasone pulse therapy (40 mg per day for three 
consecutive days every four weeks) in combination 
with daily oral colchicine (0.5 mg three times a day). 
Although dexamethasone is usually used for four cont
secutive days, we used it for only three days every four 
weeks so as to prevent fluid retention. After the 12th 
week (third pulse) cutaneous lesions started resolving 
and the Nikolsky sign was negative. After moderate 
improvement in cutaneous lesions, the patient was ret
ferred to medical oncology for further management.
DISCuSSION
Amyloidosis is a generic term that denotes extracellut
lar deposition of a proteinaceous substance composed 
of one of a family of biochemically unrelated proteins, 
usually associated with considerable tissue dysfunct
tion.1 The amyloid deposits show an appletgreen bit
refringence when specimens stained with Congo red 
are viewed under polarized light and demonstrate a 
nontbranching fibrillar structure under the electron 
microscope.2t4
Amyloidoses used to be classified clinicopathologit
cally as systemic amyloidosis (primary and myeloma 
associated or secondary), cutaneous amyloidosis (mact
ular, lichen, nodular) and heredofamilial amyloidosis. 
However, it now tends to be classified on the basis of 
characterization of the fibril proteins.5 Fibrils in prit
mary and myeloma associated systemic amyloidosis are 
composed of immunoglobulin protein AL; it occurs in 
a setting of multiple myeloma or plasma cell dyscrat
sia. In secondary systemic amyloidosis, the fibrils are 
composed of a nontimmunoglobulin protein termed 
protein AA, occurring in association with a variety of 
disease statestchronic inflammatory disorders (e.g., 
rheumatoid arthritis, ankylosing spondylitis), chronic 
infections (e.g., tuberculosis, lepromatous leprosy), 
hereditary diseases (e.g., epidermolysis bullosa of dyst
trophic and acquista types), malignant conditions (e.g., 
Hodgkin disease, nontlymphoid tumors) and various 
dermatoses (e.g., psoriasis, acne conglobata).6 Skin let
sions are found in about 40% of patients of systemic 
AL amyloidosis and rarely in patients with AA systemt
ic amyloidosis. Commonly seen cutaneous manifestat
tions include petechiae, purpura, ecchymoses, waxy 
papules and nodules.7t9
Bullous lesions as a presenting clinical feature of 
amyloidosis are very rare. There is usually associated 
multiorgan involvement. The blisters occur due to int
tratdermal splitting within the amyloid deposits. The 
contents of the blisters are often hemorrhagic because 
of intracutaneous hemorrhage due to infiltration of 
blood vessel walls by amyloid deposits, which is also 
responsible for other cutaneous features like purpura 
and ecchymoses.10t14 Acquired factor X deficiency, as 
seen in about 14% of patients with amyloidosis, may 
also contribute to the presentation of hemorrhagic bult
lae along with purpura and ecchymoses.15 
In our patient, bullae along with purpura and ect
chymoses were the presenting complaints. It was only 
after hospitalization and investigations were cont
ducted that involvement of other organs was detected. 
Our patient also had mucosal lesions; only one patient 
with mucosal lesions has been previously described.14 
Although serum and urine electrophoresis was negat
tive, characteristic mucocutaneous lesions with multit
organ involvement, positive Congotred staining in the 
skin, rectal and abdominal fat pad biopsies along with 
a positive immunostaining for immunoglobulin l were 
all in favor of primary systemic amyloidosis (AL amyt
loidosis). In addition, history and examination revealed 
no cause of secondary amyloidosis in our patient nor 
was there evidence of any heredofamilial syndrome. 
A strongly positive Nikolsky sign was also present in 
our patient, in which epidermal separation was subt
epidermal, as revealed by histopathological examinat
tion. Although classically associated with pemphigus, 
toxic epidermal necrolysis and staphylococcal scalded 
skin syndrome, Nikolsky sign has also been described 
in several other disorders; in our patient being due to 
subepidermal deposition of amyloid (pseudotNikolsky 
sign).16,17 Prognosis in primary and myeloma associated 
systemic amyloidosis is poor, the major cause of death 
being cardiac and renal failure. Cardiac involvement est
pecially indicates a very poor prognosis.18 
 The treatment of amyloidosis is often unsatisfact
tory and is directed toward the affected organ and the 
specific type of the disease.18 Various chemotherapeut
tic agents (for example, melphalan) as well as colchit
cine, thalidomide and dexamethasone have been used 
with variable response rates.18,19 Cardiac and renal 
transplantation can prolong survival.20 
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